Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bendandi

Showing results (11-20 of 72) with videos related to

Pageof 8
Sort By:
Haematologica|September 1, 1992
"Very late" relapses in Hodgkin's disease patients: a rare but real phenomenonP L Zinzani, P Mazza, F Gherlinzoni, et al.
Revista De Medicina De La Universidad De Navarra|June 9, 2007
[Anemia in chronic lymphatic leukemia: is erythropoietin the solution?]E Ruiz de Gaona, J Rifón, J Pérez-Calvo, et al.
Haematologica|July 24, 1998
To what extent can indolent lymphoma be considered? Results of a long term follow-up study from a single centerP L Zinzani, M Magagnoli, F Gherlinzoni, et al.
European Journal of Haematology|February 1, 1995
Fludarabine treatment in resistant Waldenstrom's macroglobulinemiaP L Zinzani, F Gherlinzoni, M Bendandi, et al.
Leukemia & Lymphoma|October 1, 1995
All-trans retinoic acid in the treatment of myelodysplastic syndromesG Visani, P Tosi, S Manfroi, et al.
Haematologica|March 1, 1997
Hairy-cell leukemia and alpha-interferon treatment: long-term respondersP L Zinzani, F Lauria, M Salvucci, et al.
Haematologica|November 7, 2000
Long-term follow-up after fludarabine treatment in pretreated patients with chronic lymphocytic leukemiaP L Zinzani, M Bendandi, M Magagnoli, et al.
Haematologica|May 1, 1997
Primary intestinal lymphoma: clinical and therapeutic features of 32 patientsP L Zinzani, M Magagnoli, G Pagliani, et al.
Haematologica|September 12, 2000
Value of gemcitabine treatment in heavily pretreated Hodgkin's disease patientsP L Zinzani, M Bendandi, V Stefoni, et al.
Blood|October 7, 2000
Tumor-specific recognition of human myeloma cells by idiotype-induced CD8(+) T cellsY Li, M Bendandi, Y Deng, et al.
Pageof 8

Showing results (11-20 of 72) with videos related to

Sort By:
Pageof 8
Haematologica|September 1, 1992
"Very late" relapses in Hodgkin's disease patients: a rare but real phenomenonP L Zinzani, P Mazza, F Gherlinzoni, et al.
Revista De Medicina De La Universidad De Navarra|June 9, 2007
[Anemia in chronic lymphatic leukemia: is erythropoietin the solution?]E Ruiz de Gaona, J Rifón, J Pérez-Calvo, et al.
Haematologica|July 24, 1998
To what extent can indolent lymphoma be considered? Results of a long term follow-up study from a single centerP L Zinzani, M Magagnoli, F Gherlinzoni, et al.
European Journal of Haematology|February 1, 1995
Fludarabine treatment in resistant Waldenstrom's macroglobulinemiaP L Zinzani, F Gherlinzoni, M Bendandi, et al.
Leukemia & Lymphoma|October 1, 1995
All-trans retinoic acid in the treatment of myelodysplastic syndromesG Visani, P Tosi, S Manfroi, et al.
Haematologica|March 1, 1997
Hairy-cell leukemia and alpha-interferon treatment: long-term respondersP L Zinzani, F Lauria, M Salvucci, et al.
Haematologica|November 7, 2000
Long-term follow-up after fludarabine treatment in pretreated patients with chronic lymphocytic leukemiaP L Zinzani, M Bendandi, M Magagnoli, et al.
Haematologica|May 1, 1997
Primary intestinal lymphoma: clinical and therapeutic features of 32 patientsP L Zinzani, M Magagnoli, G Pagliani, et al.
Haematologica|September 12, 2000
Value of gemcitabine treatment in heavily pretreated Hodgkin's disease patientsP L Zinzani, M Bendandi, V Stefoni, et al.
Blood|October 7, 2000
Tumor-specific recognition of human myeloma cells by idiotype-induced CD8(+) T cellsY Li, M Bendandi, Y Deng, et al.
Pageof 8